BMEA Biomea Fusion, Inc. - Common Stock
$1,38
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 5, 2026
Rango 52S
$1–$3
24% of range
Calificación del Analista
BUY
13 analysts
Precio Objetivo
$6
+371% upside
P/E (TTM)
-1.2
ROE
-216.6%
Margen de Beneficio Neto
-3326.0%
BMEA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.38
Capitalización Bursátil
$100M
P/E (TTM)
-1.2
BPA (TTM)
$-1.18
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-216.6%
Deuda/Capital
—
Rango 52S
$1 – $3
BMEA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-1.18
2020-12-31
→
2025-12-31
Flujo de caja libre
—
2021-12-31
→
2024-12-31
Márgenes
-3326.0%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BMEA
Mediana de Pares
P/E (TTM)
-1.2
0.8
P/B (P/C)
3.4
5.5
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BMEA
Mediana de Pares
Operating Margin (Margen Operativo)
-4494.7%
—
Net Profit Margin (Margen de Beneficio Neto)
-3326.0%
-3742.1%
ROA
-89.2%
-49.4%
ROE
-216.6%
-59.3%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BMEA
Mediana de Pares
Current Ratio (Ratio corriente)
5.2
4.9
Quick Ratio (Ratio Rápido)
5.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BMEA
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-67.1%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BMEA
Mediana de Pares
BMEA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
13 analistas
- Compra fuerte 5 38,5%
- Compra 6 46,2%
- Mantener 1 7,7%
- Venta 1 7,7%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
6 analistas · 2026-08-18
Mediana
$7.00
Media
$6.50
← Por Debajo de Todos los Objetivos
$1.38
Mín
$4.00
Máx
$9.00
Objetivo mediano
$7.00
+407,2%
Objetivo medio
$6.50
+371,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.10%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.12 | $-0.23 | 0.11% |
| 31 de marzo de 2026 | $-0.17 | $-0.24 | 0.07% |
| 31 de diciembre de 2025 | $0.27 | $-0.26 | 0.53% |
| 30 de septiembre de 2025 | $-0.27 | $-0.26 | -0.01% |
| 30 de junio de 2025 | $-0.51 | $-0.54 | 0.03% |
| 31 de marzo de 2025 | $-0.80 | $-0.62 | -0.18% |
| 31 de diciembre de 2024 | $-0.81 | $-0.94 | 0.13% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | — |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| FBIO | — | — | — | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 11
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $62M | $118M | $103M | $63M | $28M | $4M | |
| SG&A Expense | $19M | $26M | $24M | $21M | $14M | $2M | |
| Operating Expenses | $84M | $144M | $126M | $84M | $42M | $5M | |
| Operating Income | $-84M | $-144M | $-126M | $-84M | $-42M | $-5M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-62M | $-138M | $-117M | $-82M | $-42M | $-5M | |
| EPS (Basic) | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 | $-0.51 | |
| EPS (Diluted) | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 | $-0.51 | |
| Shares (Basic) | 52,228,068 | 36,105,671 | 34,106,923 | 29,271,777 | 23,858,552 | 10,532,942 | |
| Shares (Diluted) | 52,228,068 | 36,105,671 | 34,106,923 | 29,271,777 | 23,858,552 | 10,532,942 | |
| EBITDA | $-84M | $-144M | $-126M | $-84M | $-42M | · |
Balance general 23
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $58M | $177M | $112M | $146M | $62M | |
| Short-term Investments | · | · | · | $1M | $28M | · | |
| Receivables | · | · | · | · | · | $16.0K | |
| Prepaid Expense | $2M | $10M | $2M | $5M | $3M | $528.0K | |
| Other Current Assets | · | · | · | · | · | $29.0K | |
| Current Assets | $58M | $68M | $179M | $118M | $177M | $62M | |
| PP&E (Net) | $153.0K | $4M | $5M | $6M | $3M | $81.0K | |
| PP&E (Gross) | $1M | $8M | $8M | $7M | $3M | $89.0K | |
| Accum. Depreciation | $1M | $4M | $2M | $916.0K | $257.0K | $8.0K | |
| Other Non-current Assets | $0 | $619.0K | $6M | $3M | $1M | $12.0K | |
| Total Assets | $59M | $80M | $200M | $129M | $186M | $63M | |
| Accounts Payable | $3M | $13M | $7M | $7M | $1M | $727.0K | |
| Accrued Liabilities | · | · | · | · | · | $633.0K | |
| Current Liabilities | $11M | $22M | $23M | $19M | $5M | $2M | |
| Capital Leases | $128.0K | $7M | $8M | $2M | $2M | · | |
| Total Liabilities | $29M | $28M | $31M | $21M | $7M | $2M | |
| Common Stock | $7.0K | $4.0K | $4.0K | $3.0K | $3.0K | $1.0K | |
| Paid-in Capital | $479M | $439M | $418M | $240M | $229M | $13M | |
| Retained Earnings | $-449M | $-387M | $-249M | $-132M | $-50M | $-8M | |
| AOCI | · | · | · | $-1.0K | $-10.0K | · | |
| Stockholders' Equity | $30M | $52M | $169M | $109M | $179M | $5M | |
| Liabilities + Equity | $59M | $80M | $200M | $129M | $186M | $63M | |
| Shares Outstanding | 72,299,440 | 36,310,713 | 35,866,610 | 29,561,554 | 29,115,421 | 11,953,107 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $19M | $14M | $10M | $6M | $322.0K | |
| Operating Cash Flow | $-70M | $-120M | $-97M | $-62M | $-35M | $-4M | |
| CapEx | · | $362.0K | $3M | $1M | $3M | $51.0K | |
| Investing Cash Flow | · | $-362.0K | $-2M | $27M | $-33M | $-51.0K | |
| Stock Issued | $5M | · | $162M | · | · | $10M | |
| Net Stock Activity | $5M | · | $162M | · | · | · | |
| Financing Cash Flow | $68M | $2M | $164M | $1M | $153M | $66M | |
| Net Change in Cash | $-2M | $-119M | $65M | $-34M | $84M | $61M | |
| Free Cash Flow | · | $-120M | $-100M | $-63M | $-39M | · |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -4494.7% | · | · | · | · | · | |
| Net Margin | -3326.0% | · | · | · | · | · | |
| EBITDA Margin | -4494.7% | · | · | · | · | · | |
| ROA | -89.2% | -98.9% | -71.2% | -51.9% | -33.5% | · | |
| ROE | -216.6% | -217.1% | -63.6% | -68.4% | -22.5% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 3.2 | 7.8 | 6.2 | 38.1 | · | |
| Quick Ratio | 5.0 | 2.7 | 7.7 | 5.9 | 37.4 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.1% | -36.4% | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-62M | $-138M | $-117M | $-82M | $-42M | · | |
| Market Cap | $90M | $141M | $521M | $249M | $217M | · | |
| P/E | -1.1 | -1.0 | -4.2 | -3.0 | -4.3 | · | |
| P/B | 3.0 | 2.7 | 3.1 | 2.3 | 1.2 | · | |
| P / Tangible Book | 3.0 | 2.7 | 3.1 | 2.3 | 1.2 | · | |
| P / Cash Flow | -1.3 | -1.2 | -5.4 | -4.0 | -6.1 | · | |
| P / FCF | · | -1.2 | -5.2 | -3.9 | -5.6 | · | |
| Earnings Yield | -95.2% | -98.7% | -23.7% | -33.2% | -23.4% | · |
Estado de resultados 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $165M | |
| R&D Expense | $9M | $9M | $8M | $14M | $17M | $23M | $25M | $27M | $32M | $34M | $31M | $25M | $22M | $24M | $21M | $18M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $5M | $7M | $5M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $5M | |
| Operating Expenses | $13M | $13M | $12M | $21M | $21M | $30M | $30M | $34M | $39M | $41M | $37M | $31M | $28M | $30M | $26M | $23M | |
| Operating Income | $-13M | $-13M | $-12M | $-21M | $-21M | $-30M | $-30M | $-34M | $-39M | $-41M | $-37M | $-31M | $-28M | $-30M | $-26M | $-23M | |
| Net Income | $-8M | $-12M | $5M | $-16M | $-21M | $-29M | $-29M | $-33M | $-37M | $-39M | $-35M | $-28M | $-25M | $-29M | $-25M | $-23M | |
| EPS (Basic) | $-0.12 | $-0.17 | $0.40 | $-0.27 | $-0.51 | $-0.80 | $-0.80 | $-0.91 | $-1.03 | $-1.09 | $-0.96 | $-0.80 | $-0.70 | $-0.98 | $-0.87 | $-0.78 | |
| EPS (Diluted) | $-0.12 | $-0.17 | $0.40 | $-0.27 | $-0.51 | $-0.80 | $-0.80 | $-0.91 | $-1.03 | $-1.09 | $-0.96 | $-0.80 | $-0.70 | $-0.98 | $-0.87 | $-0.78 | |
| Shares (Basic) | 72,360,235 | 72,299,440 | -84,877,808 | 59,848,325 | 40,630,403 | 36,627,148 | -72,048,996 | 36,220,736 | 36,043,561 | 35,890,370 | -66,481,826 | 35,653,988 | 35,348,293 | 29,586,468 | -58,369,751 | 29,319,042 | |
| Shares (Diluted) | 72,360,235 | 72,299,440 | -84,877,808 | 59,848,325 | 40,630,403 | 36,627,148 | -72,048,996 | 36,220,736 | 36,043,561 | 35,890,370 | -66,481,826 | 35,653,988 | 35,348,293 | 29,586,468 | -58,369,751 | 29,319,042 | |
| EBITDA | $-13M | $-13M | · | $-21M | $-21M | $-30M | · | $-34M | $-39M | $-41M | · | $-31M | $-28M | $-30M | · | $-23M |
Balance general 20
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $45M | $56M | $47M | $56M | $36M | $58M | $88M | $113M | $145M | $177M | $199M | $223M | $86M | $112M | $132M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Prepaid Expense | $1M | $1M | $2M | $3M | $8M | $9M | $10M | $6M | $3M | $3M | · | $3M | $3M | $3M | · | $5M | |
| Current Assets | $36M | $46M | $58M | $49M | $65M | $45M | $68M | $94M | $116M | $148M | · | $203M | $226M | $89M | · | $139M | |
| PP&E (Net) | $47.0K | $67.0K | $153.0K | $200.0K | $3M | $3M | $4M | $4M | $4M | $5M | · | $6M | $6M | $6M | · | $3M | |
| PP&E (Gross) | · | $668.0K | $1M | $1M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | $4M | |
| Accum. Depreciation | · | $601.0K | $1M | $962.0K | $5M | $5M | $4M | $4M | $3M | $3M | · | $2M | $2M | $1M | · | $733.0K | |
| Other Non-current Assets | $398.0K | · | $0 | $0 | $4.0K | $617.0K | $619.0K | $5M | $7M | $7M | · | $5M | $4M | $4M | · | · | |
| Total Assets | $37M | $46M | $59M | $55M | $73M | $55M | $80M | $110M | $136M | $168M | · | $225M | $249M | $113M | · | $145M | |
| Accounts Payable | $3M | $5M | $3M | $6M | $8M | $8M | $13M | $9M | $6M | $5M | · | $3M | $4M | $5M | · | $2M | |
| Current Liabilities | $10M | $9M | $11M | $16M | $18M | $20M | $22M | $28M | $25M | $25M | · | $16M | $14M | $19M | · | $13M | |
| Capital Leases | $0 | $0 | $128.0K | $6M | $6M | $7M | $7M | $7M | $7M | $8M | · | $9M | $10M | $11M | · | $2M | |
| Total Liabilities | $25M | $28M | $29M | $40M | $46M | $26M | $28M | $34M | $32M | $33M | · | $25M | $24M | $30M | · | $14M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | $4.0K | $4.0K | $3.0K | · | $3.0K | |
| Paid-in Capital | $482M | $480M | $479M | $469M | $465M | $445M | $439M | $434M | $429M | $423M | · | $414M | $410M | $244M | · | $237M | |
| Retained Earnings | $-470M | $-461M | $-449M | $-454M | $-437M | $-417M | $-387M | $-358M | $-325M | $-288M | · | $-214M | $-186M | $-161M | · | $-106M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-13.0K | |
| Stockholders' Equity | $12M | $19M | $30M | $16M | $28M | $29M | $52M | $76M | $104M | $135M | $169M | $200M | $224M | $83M | $109M | $131M | |
| Liabilities + Equity | $37M | $46M | $59M | $55M | $73M | $55M | $80M | $110M | $136M | $168M | · | $225M | $249M | $113M | · | $145M | |
| Shares Outstanding | 72,483,852 | 72,299,440 | 72,299,440 | 59,508,518 | 58,127,256 | 37,572,250 | 36,310,713 | 36,238,280 | 36,184,485 | 35,933,586 | · | 35,698,847 | 35,630,276 | 29,651,134 | · | 29,388,753 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-10M | $-12M | $-14M | $-12M | $-19M | $-26M | $-30M | $-25M | $-33M | $-32M | $-23M | $-24M | $-26M | $-24M | $-20M | $-17M | |
| CapEx | · | · | · | $0 | $0 | $0 | $82.0K | $186.0K | $59.0K | $35.0K | $8.0K | $39.0K | $417.0K | $3M | $712.0K | $-50.0K | |
| Investing Cash Flow | $0 | $550.0K | · | $0 | $0 | $0 | $-82.0K | $-186.0K | $-59.0K | $-35.0K | $-8.0K | $-39.0K | $-417.0K | $-2M | $-701.0K | $225.0K | |
| Stock Issued | · | · | $-124.0K | $0 | $2M | $3M | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $23M | $2M | $40M | $3M | $413.0K | $69.0K | $1M | $116.0K | $622.0K | $138.0K | $163M | $201.0K | $490.0K | $400.0K | |
| Net Change in Cash | $-10M | $-11M | $9M | $-10M | $20M | $-22M | $-30M | $-25M | $-32M | $-32M | $-22M | $-24M | $137M | $-26M | $-20M | $-16M | |
| Free Cash Flow | · | · | · | · | · | $-26M | · | · | · | $-32M | · | · | · | $-27M | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4001.9% | -2970.7% | · | -473.1% | -3969.4% | -6602.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -2610.7% | -2887.2% | · | -373.1% | -3869.4% | -6502.7% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -4001.9% | -2970.7% | · | -473.1% | -3969.4% | -6602.7% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -15.1% | -24.5% | · | -19.8% | -19.8% | -26.2% | · | -19.5% | -19.4% | -27.8% | · | -15.4% | -12.1% | -20.2% | · | -13.3% | |
| ROE | -42.0% | -52.3% | · | -35.8% | -31.6% | -35.7% | · | -23.8% | -22.7% | -35.8% | · | -17.2% | -13.3% | -23.4% | · | -14.2% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 5.0 | · | 3.2 | 3.7 | 2.3 | · | 3.4 | 4.6 | 5.8 | · | 12.5 | 15.7 | 4.7 | · | 11.0 | |
| Quick Ratio | 3.3 | 4.8 | · | 3.0 | 3.2 | 1.8 | · | 3.2 | 4.5 | 5.7 | · | 12.3 | 15.5 | 4.6 | · | 10.6 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-58M | $-79M | · | $-96M | $-112M | $-129M | · | $-144M | $-140M | $-127M | · | $-108M | $-102M | $-95M | · | $-71M | |
| Market Cap | $107M | $111M | · | $120M | $105M | $80M | · | $366M | $163M | $537M | · | $491M | $782M | $919M | · | $287M | |
| P/E | -1.4 | -0.9 | · | -0.8 | -0.6 | -0.6 | · | -2.5 | -1.2 | -4.2 | · | -4.1 | -6.6 | -9.7 | · | -4.0 | |
| P/B | 8.8 | 5.9 | · | 7.7 | 3.8 | 2.8 | · | 4.8 | 1.6 | 4.0 | · | 2.5 | 3.5 | 11.1 | · | 2.2 | |
| P / Tangible Book | 8.8 | 5.9 | · | 7.7 | 3.8 | 2.8 | · | 4.8 | 1.6 | 4.0 | · | 2.5 | 3.5 | 11.1 | · | 2.2 | |
| P / Cash Flow | · | -9.5 | · | · | · | -3.1 | · | · | · | -16.8 | · | · | · | -38.2 | · | · | |
| P / FCF | · | · | · | · | · | -3.1 | · | · | · | -16.8 | · | · | · | -34.1 | · | · | |
| Earnings Yield | -72.8% | -114.4% | · | -118.3% | -168.3% | -166.7% | · | -39.7% | -86.7% | -23.9% | · | -24.3% | -15.1% | -10.3% | · | -24.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margen Operativo % | -4494.7% | — | — | — | — |
| Beneficio neto | $-62M | $-138M | $-117M | $-82M | $-42M |
| EPS Diluido | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 5.2 | 3.2 | 7.8 | 6.2 | 38.1 |
| Ratio Rápido | 5.0 | 2.7 | 7.7 | 5.9 | 37.4 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | — | $-120M | $-100M | $-63M | $-39M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 74 declarantes · $27.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 11 (-3 vs trimestre anterior) | 14 (+6 vs trimestre anterior) | 22 (+5 vs trimestre anterior) | 10 (-6 vs trimestre anterior) | +4.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $7 170 501 | 4 877 892 | 26,29% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $4 159 993 | 2 829 927 | 15,25% | Acciones |
| Aisling Capital Management LP | $3 011 673 | 2 048 757 | 11,04% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $2 139 547 | 1 455 474 | 7,85% | Acciones |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $1 063 069 | 723 176 | 3,90% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $900 720 | 612 735 | 3,30% | Acciones |
| Mariner, LLC | $874 247 | 594 726 | 3,21% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $864 837 | 588 010 | 3,17% | Acciones |
| JANE STREET GROUP, LLC | $673 685 | 458 289 | 2,47% | Acciones |
| XTX Topco Ltd | $598 112 | 406 879 | 2,19% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $585 795 | 398 500 | 2,15% | Opción de compra |
| TWO SIGMA INVESTMENTS, LP | $565 155 | 384 459 | 2,07% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $497 367 | 338 345 | 1,82% | Acciones |
| MARSHALL WACE, LLP | $443 938 | 301 999 | 1,63% | Acciones |
| MAI Capital Management | $424 977 | 289 100 | 1,56% | Acciones |
| STATE STREET CORP | $378 253 | 257 315 | 1,39% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $317 226 | 215 800 | 1,16% | Opción de venta |
| CITADEL ADVISORS LLC | $262 101 | 178 300 | 0,96% | Opción de compra |
| UBS Group AG | $198 848 | 135 271 | 0,73% | Acciones |
| NORTHERN TRUST CORP | $188 933 | 128 526 | 0,69% | Acciones |
| JANE STREET GROUP, LLC | $180 810 | 123 000 | 0,66% | Opción de compra |
| Headlands Technologies LLC | $163 683 | 111 349 | 0,60% | Acciones |
| Marex Group Ltd | $147 000 | 100 000 | 0,54% | Acciones |
| TWO SIGMA ADVISERS, LP | $131 192 | 105 800 | 0,48% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $124 362 | 84 600 | 0,46% | Acciones |
| LMR Partners LLP | $114 000 | 100 000 | 0,42% | Acciones |
| Jain Global LLC | $111 276 | 75 698 | 0,41% | Acciones |
| GRIFFIN ASSET MANAGEMENT, INC. | $87 906 | 59 800 | 0,32% | Acciones |
| SUPERSTRING CAPITAL MANAGEMENT LP | $85 306 | 250 000 | 0,31% | Acciones |
| Graham Capital Management, L.P. | $78 579 | 53 455 | 0,29% | Acciones |
| CITADEL ADVISORS LLC | $66 027 | 44 916 | 0,24% | Acciones |
| ADAR1 Capital Management, LLC | $63 827 | 43 420 | 0,23% | Acciones |
| Rathbones Group PLC | $54 390 | 37 000 | 0,20% | Acciones |
| Vanguard Global Advisers, LLC | $50 900 | 34 626 | 0,19% | Acciones |
| Point72 Asset Management, L.P. | $48 204 | 32 792 | 0,18% | Acciones |
| VANGUARD GROUP INC | $42 936 | 34 626 | 0,16% | Acciones |
| WOLVERINE TRADING, LLC | $36 462 | 17 700 | 0,13% | Opción de compra |
| Bank of New York Mellon Corp | $23 182 | 15 770 | 0,09% | Acciones |
| BlackRock, Inc. | $22 938 | 15 604 | 0,08% | Acciones |
| CFS Investment Advisory Services, LLC | $22 303 | 15 818 | 0,08% | Acciones |
| BIRCH FINANCIAL GROUP, LLC | $20 580 | 14 000 | 0,08% | Acciones |
| TWO SIGMA SECURITIES, LLC | $20 545 | 13 976 | 0,08% | Acciones |
| Point72 Asia (Singapore) Pte. Ltd. | $20 259 | 10 029 | 0,07% | Acciones |
| GOLDMAN SACHS GROUP INC | $19 580 | 13 320 | 0,07% | Acciones |
| CITADEL ADVISORS LLC | $19 404 | 13 200 | 0,07% | Opción de venta |
| Qube Research & Technologies Ltd | $18 668 | 12 699 | 0,07% | Acciones |
| PNC Financial Services Group, Inc. | $17 640 | 12 000 | 0,06% | Acciones |
| NewEdge Advisors, LLC | $17 640 | 12 000 | 0,06% | Acciones |
| Creative Planning | $17 640 | 12 000 | 0,06% | Acciones |
| OSAIC HOLDINGS, INC. | $15 876 | 10 800 | 0,06% | Acciones |
| FORTEM FINANCIAL GROUP, LLC | $14 700 | 10 000 | 0,05% | Acciones |
| MORGAN STANLEY | $13 193 | 8 975 | 0,05% | Acciones |
| HAP Trading, LLC | $11 160 | 24 800 | 0,04% | Opción de compra |
| FEDERATED HERMES, INC. | $11 003 | 7 485 | 0,04% | Acciones |
| SBI Securities Co., Ltd. | $10 425 | 7 092 | 0,04% | Acciones |
| Federation des caisses Desjardins du Quebec | $9 555 | 6 500 | 0,04% | Acciones |
| CITIGROUP INC | $6 906 | 4 698 | 0,03% | Acciones |
| HAP Trading, LLC | $6 820 | 24 800 | 0,03% | Opción de compra |
| Cubist Systematic Strategies, LLC | $6 805 | 3 369 | 0,02% | Acciones |
| SIGNATUREFD, LLC | $5 163 | 3 500 | 0,02% | Acciones |
| AlphaQuest LLC | $4 101 | 3 307 | 0,02% | Acciones |
| Rockefeller Capital Management L.P. | $2 940 | 2 000 | 0,01% | Acciones |
| Nuveen Asset Management, LLC | $2 281 | 588 | 0,01% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 548 | 1 053 | 0,01% | Acciones |
| BARCLAYS PLC | $1 405 | 956 | 0,01% | Acciones |
| Fortitude Family Office, LLC | $667 | 454 | 0,00% | Acciones |
| Global Retirement Partners, LLC | $551 | 375 | 0,00% | Acciones |
| Glen Eagle Advisors, LLC | $368 | 250 | 0,00% | Acciones |
| GSA CAPITAL PARTNERS LLP | $318 | 216 020 | 0,00% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $169 | 128 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $150 | 108 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $100 | 68 | 0,00% | Acciones |
| COMERICA BANK | $25 | 20 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $0 | 99 | 0,00% | Acciones |
Informantes de la empresa 12 insiders · 5 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Michael J.M. Hitchcock | Interim CEO | 1 de abril de 2026 A | 115 000 | 1 | 0 | $99 000 |
| Thomas Andrew Butler | Chief Executive Officer | 17 de enero de 2024 A | — | 0 | 0 | $0 |
| Franco Valle | Chief Financial Officer | 30 de noviembre de 2024 A | 42 995 | 0 | 0 | $0 |
| Rainer M Erdtmann | President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer | 1 de abril de 2026 A | 723 027 | 3 | 0 | $97 400 |
| Juan Pablo Frias | Chief Medical Officer | 31 de mayo de 2024 A | 349 | 0 | 0 | $0 |
| Julianne Averill | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Sumita Ray | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Elizabeth Faust | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Eric Aguiar | Consejero | 10 de junio de 2026 A | — | 0 | 0 | $0 |
| Sotirios Stergiopoulos | Consejero | 17 de septiembre de 2021 P | 4 400 000 | 0 | 0 | $0 |
| Biomea Health, LLC | Propietario del 10% | 1 de junio de 2022 J | 0 | 0 | 0 | $0 |
| A2A Pharmaceuticals, Inc. | Propietario del 10% | 17 de septiembre de 2021 P | 4 400 000 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP, Chen Bihua ×5 presentaciones | 24 de octubre de 2025 | 1,53% | Enmienda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.